Tender Notice for the Curtain Wall Works of the Minhai Biotechnology New‑Type Vaccine International Industrial Base Construction Project

Release date:

2021-04-09

Author:

Source:


Abstract

I. Project Name: Minhai Biotechnology New‑Type Vaccine International Industrial Base Construction Project II. Project Overview: The Minhai Biotechnology New‑Type Vaccine International Industrial Base Construction Project, invested and developed by Beijing Minhai Biotechnology Co., Ltd., is located on parcels 0503‑039, 040, 043, and 044 within the Daxing Biopharmaceutical Industry Base. The project’s boundaries are as follows: to the north, Simiao Road; to the south, the planned land‑use boundary (municipal green space); to the west, Xiangrui Avenue; and to the east, Tianfu Avenue. This project is primarily intended for the research, development, and production of human vaccines. Construction Scale: The total land area is 90,013.218 m², with a total floor area of 1…

I. Project Name Minhai Biotechnology’s New Vaccine International Industrial Base Construction Project

 

II. Project Overview:

Project Overview: The Minhai Biologics International Vaccine Industrial Base Project, invested in and constructed by Beijing Minhai Biotechnology Co., Ltd., is located within the Daxing Biopharmaceutical Industry Base. 0503-039 040043044 The site is bounded as follows: to the north by Simiao Road, to the south by the planned land‑use boundary (municipal green space), to the west by Xiangrui Avenue, and to the east by Tianfu Avenue. This project is primarily intended for the research, development, and production of human vaccines.

Construction scale: Total land area 90013.218m2 , with a total floor area of 187684.83m2 (Where the above-ground floor area is 130410.84m2 , underground floor area 57273.99m2 )。Building height 33.3 Rice, underground 1 Layer, above ground 7 Floor, basement floor-to-ceiling height 6 Rice, ground-floor ceiling height 3.8-7.9 Rice, green space ratio 15% , floor area ratio 1.5 , building density 40%    

Construction period: 2021 year 6 month -2021 year 9 Month.

 

III. Scope of the Tender:

1 , Tender Content: The scope of this tender pertains to the construction project of Minhai Biologics’ Internationalization Industrial Base for Novel Vaccines. 115 Within the scope of the curtain wall design for Building No. __, this includes detailed design of specific structural details, material procurement, construction, and warranty services.

l Specific scope: 1 R&D pilot workshop, 2 R&D Technology Workshop, 3 Comprehensive Service Building, 4 Number of experimental animal facilities, 5 Hazardous waste and dangerous goods warehouse, 6 sewage treatment plant, 7 Boiler Room No., 8 Vaccine Production Building No. , 9 Number packaging and warehouse building, 10 Bacterial vaccine production building, 13 Gatehouse and carport, 14 Gatekeeper, 15 The curtain wall and exterior facade works of the gatehouse, 12 Doors and windows within the scope of the basement-level sunken plaza.

l   Curtain wall area : Approximately 60000 square meter

 

IV. Registration Instructions:

1 Units participating in the registration must meet the qualification requirements.
    ( 1 ) Enterprise qualification requirements: Bidders must possess independent legal person status and a valid business license, enjoy a good commercial reputation, and have registered capital. 10000 10,000 or more; The bidder shall possess a Grade-A qualification for architectural curtain wall engineering design and a Level-1 specialized contracting qualification for architectural curtain wall engineering construction, both issued by the competent construction administrative authority, as well as a valid safety production license.

( 2 ) Project Manager Qualification Requirements: The proposed project manager must hold a National Grade-I Registered Construction Engineer qualification in architectural engineering (registered with the applying organization; temporary practice certificates are not accepted) and possess a valid certificate of passing the safety production assessment. B certificate), and has no ongoing construction projects or projects currently under contract.

( 3 ) Corporate performance requirements: Enterprise 2018 year 4 month 1 Since [date], the contractor has demonstrated comparable construction performance: no fewer than three ongoing or completed projects, with individual contract amounts for curtain wall systems of at least… 6000 RMB 10,000 or more (with the date of the contract, the completion acceptance report, or the settlement statement serving as the determining date).

( 4 ) Project Manager Performance Requirements Project Manager 2018 year 4 month 1 Since [date], has demonstrated comparable construction performance (with individual contract curtain wall amounts of…). 6000 For contracts valued at RMB 10,000 or above, the contract signing date shall prevail; the project manager’s name must be indicated in the contract agreement.

Note: Enterprise and project manager performance records must not be duplicated.

( 5 ) Credit requirements: The enterprise is not subject to an order to suspend operations, has not had its bidding qualifications revoked, nor is its property under receivership, frozen, or in bankruptcy; furthermore, the enterprise has not been found to have engaged in fraudulent practices to secure a bid, committed serious breaches of contract, or caused major incidents involving engineering quality or workplace safety, and is not currently within a suspension period imposed by the relevant authorities.

2 The tendering entity will review the qualification documents of all registered entities, giving priority to those with relevant project experience, and will conduct further discussions and on-site inspections with the shortlisted candidates.

3 Beijing Minhai Biotechnology Co., Ltd. was established in 2004 Year is a wholly owned subsidiary of Shenzhen Kangtai Biological Products Co., Ltd. (a publicly listed company). For more information, please visit the company’s website. Our website address is: http://www.biominhai.com/

 

V. Registration Method:

1 The bidder shall send the registration email and electronic copies of the relevant qualification documents to the registration email address, and mail the hard copies to the procuring entity.

Registration Email mhzb@biominhai.com

Shipping Address: Simiao Road, Biomedical Industry Base, Daxing District, Beijing 35 Number

Recipient: Mr. Wu and Ms. Fang, New Project Department, Beijing Minhai Biotechnology Co., Ltd.

2. Eligibility Documents:

( 1 ) Registration requires providing the contact person and contact information of the submitting organization. The contact person must be the project leader or an designated business liaison, and must also provide… 12 Monthly social security certificate;

( 2 ) Original identity card of the legal representative or authorized representative;
( 3 ) Applicant’s Basic Information Form;
( 4 ) Original and photocopies of the enterprise qualification certificate and the safety production license, stamped with the enterprise’s valid seal;
( 5 ) Original and photocopies of the business license (certified as valid upon annual inspection), the organization code certificate, the tax registration certificate, and other aforementioned documents, all stamped with the company’s official seal.

( 6 ) Audited financial statements for the enterprise for the past three years, bank or recognized credit rating, 2021 The annual credit limit available for use.
( 7 ) Project Manager’s CV and a summary of similar projects completed by the company over the past three years: Attach the applicant’s award notification. Or, directly submit the subcontracting filing procedures; original and copy of the completed contract for similar projects, stamped with the company’s official seal; original and copy of the qualification certificates of the project manager and key management personnel, also stamped with the company’s official seal.
( 8 ) Photocopies of the labor contracts and social security payment certificates for all registered personnel (including the authorized representative, project manager, and key management personnel), stamped with the official seal, shall be submitted.
( 9 ) Applicant’s Undertaking Letter (stating that all submitted documents and certificates are true, accurate, complete, and valid);

All photocopies of the aforementioned documents must be stamped with the company’s official seal and bound in a simple manner.
2
, Contact Information:

Contact persons: Ms. Fang and Mr. Wu, New Engineering Project Department; contact phone: 13312168695.

 

VI. Registration Deadline: 2021 year 4 month 20 day 5:30 PM Time.

Hereby announced!

 

 

Beijing Minhai Biotechnology Co., Ltd.

2021 year 4 month 8 day

 

Recommended Reading


Batch Release Status of the Company’s Products in 2026


The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.


Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.


Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09